Document e7ng1Owb0g6L4K6bn8ZYk3Mpy

To: richard.irons@cinpathogen.com <richard.irons@cinpathogen.com> From: Howard Feldman <Feldman@api.org> Cc: BenzConsort-OC@listserve.api.org <BenzConsort-OC@listserve.api.org>; BenzConsort-TC@listserve.api.org <BenzConsort-TC@listserve.api.org>; Brenda Hargett <Hargettb@api.org>; Bob Greco <Greco@api.org>; Harry Ng <Ng@api.org> Bcc: Received Date: 2007-05-07 15:40: 12 GMT Subject: Shanghai Health Study - Cinpathogen Milestones Dr. Irons, The Benzene Health Research Consortium has revised the milestone reporting request as described in the attached document. The milestones set forth herein are to allow API and the Oversight Committee to fulfill their obligations to monitor costs and the progress of the study. Please contact me if you have any questions. Howard Feldman From: Russell White [mailto:whiter@api.org] Sent: Wednesday, April 18, 20075:18 PM To: Richard.lrons@UCHSC.edu Cc: BenzConsort-OC@listserve.api.org; BenzConsort-TC@listserve.api.org; Brenda Hargett; Bob Greco; Harry Ng Subject: Shanghai Health Study - Cinpathogen Draft Deliverables Dr. Irons, Attached is a revised draft of near-term and long-term deliverables and milestones that should help you meet the conditions for advanced payment set out in Mr. Cavaney's letter of April 11 ,2007. They have been reviewed by API and sponsoring company representatives. They are still very similar to the list Michael Bird and I reviewed with you on April 13. I still have some follow-up work to do with Rob Schnatter on two of the items, but his input should not change the overall goal of the deliverable. Please let me know if you want to discuss anything related to these deliverables or the contract budget issues. Regards, Russ > SH ELL-MCCLU RG-062088 Russell White Regulatory and Scientific Affairs American Petroleum Institute 1220 L Street NW Washington, DC 20005-4070 Tel: 202-682-8344 Fax: 202-682-8270 Attachments: API_ Cinpathogen Contract Milestones Memo (2).doc SH ELL-MCCLU RG-062089